“an increasing trend”

Although no significant differences were observed, an increasing trend with age was noted ( p = 0.156, Figure 1B ).

Post hoc Bonferroni showed that EphB1‐3 receptor protein levels of MIA offspring had an increasing trend at PND45 ( p = 0.1575) but an obvious increase at PND65 compared with the control groups ( p = 0.0152) (Figure 4E ).

The values of hs -CRP showed an increasing trend that did not reach significance (P = 0.16).

Although it seems that there is an increasing trend across the years, the data are not statistically significant, potentially due to wide confidence intervals (χ 2 = 6.59; df = 4; P = 0.16).

In contrast, an increasing trend of 20.9% to 26.7% ( p = 0.16) and a significantly increasing trend of 27.4% to 41.3% ( p = 0.0021) were observed for ATX and GXR, respectively.

After nystatin treatment, the expression of IL-4 exhibited an increasing trend (treated group vs. untreated 15 d sub-group, 10.67 ± 2.066 vs. 8.17 ± 3.488, respectively, P = 0.162).

The complication rates showed an increasing trend in order to S-ReSC score groups (1.87% [14/75] vs. 28.6% [12/42] vs. 34.2% [13/38], respectively; p = 0.166).

4 A), and the number of muscle fibres per unit area showed an increasing trend at 1 d of age ( P = 0.167, Fig. 3 B).

We observed significant increase in DPT cell absolute numbers (cisplatin 231.8 ± 51.72 vs control 92.50 ± 35.44, P ≤ 0.01) and an increasing trend in the percentage (cisplatin 0.40 ± 0.14% vs control 0.16 ± 0.03%, P = 0.17) in cisplatin treated mice compared to vehicle control mice at 72 h (Fig. 6 A).

Similarly, the maximum neointimal thickness showed an increasing trend (0.7–0.8 mm, p = 0.17).

Fertilization rates showed an increasing trend (F 2,12 = 2.03; p = 0.17) as the dose of E 2 increased ( Fig 6 ).

At Day 14 the placebo drove an increasing trend in perceived malodor (median change = +20%; p = 0.17, one-tailed paired Wilcoxon test), whereas perceived malodor for the COHP group did not change (median change = 0%; p = 0.29, one-tailed paired Wilcoxon test).

An increasing trend in the frequency of PTEN protein loss has been observed in men ( p = 0.171) with metastases to regional lymph nodes ( p = 0.263), in stage IV ( p = 0.250), and in patients with positive smoking status ( p = 0.055) ( Table 1 ).

The beta-cell area showed an increasing trend ( P = 0.173), whereas the alpha-cell area remained unchanged following dapagliflozin treatment [Figure 2 D−F].

Results Effects of LPS on IL-6 concentration LPS-treated mice showed a significant increase in IL-6 concentration in the serum ( Fig 3A ) (p = 0.0002) and an increasing trend in the supernatant of the brain tissue, i . e ., the cerebral cortex, including the ACC ( Fig 3B ) (p = 0.177).

An increasing trend in the abundance of Firmicutes and the Firmicutes/Bacteroidetes ratio (F/B ratio) was observed in the FMT-TD group compared to the CON group ( p = 0.180) (Supplementary Fig. 1d ; Fig. 2e ).

Additionally, there was an increasing trend in the abundance of Lactobacillaceae ( p = 0.18) and Bifidobacteriaceae after L. reuteri DYNDL22M62 treatment.

cloacae in COPD and asthma, there was an increasing trend of 0.20 SMD ( P = 0.18).

An increasing trend in brain-derived neurotrophic factor (BDNF) levels was observed (1.32-fold, adjusted p = 0.18), which may support previous evidence of fasting's neuroprotective effects [ 14 ].

In the current study, although the crude comparison was non-significant, there was an increasing trend of mortality in combination therapy (20/75 (26.6%) vs. 17/94 (18.1%), p = 0.180).

There was an increasing trend in 6MWT when training weeks increased from 7 to 12 ( P = 0.18, coefficient = 5.04, 95% CI − 2.93–13.02) and training frequency increased from 1.5 (average) to 7 times per week ( P = 0.34, coefficient = 3.30, 95% CI − 4.16–10.76) (see Supplementary Figs.

Skin hydration on the cheek had an increasing trend with probiotic supplementation ( Figure 3 , p = 0.18) but not with placebo.

On the whole, Prevotella showed a decreasing trend ( P = 0.18), Neisseria showed an increasing trend ( P = 0.34), Capnocytophaga decreased at first and then increased, while Leptotrichia showed little change.

Even if there is an increasing trend ( p = 0.1822 for cortical porosity) of bone loss in the nefopam group compared to the control group, cortical porosity and bone volume/total volume (BV/TV) were not different between the two groups ( Figures 3B,C ).

Although average July temperatures also recorded an increasing trend, this was not significant ( R 2 = .050, F = 1.825, p = .185).